153 related articles for article (PubMed ID: 20652713)
1. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
[TBL] [Abstract][Full Text] [Related]
2. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
4. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine whole blood concentrations in cases with positive oral fluid on-site screening test results using the DrugWipe(®) single for benzodiazepines.
Blencowe T; Vimpari K; Lillsunde P
J Anal Toxicol; 2011 Jul; 35(6):349-56. PubMed ID: 21740691
[TBL] [Abstract][Full Text] [Related]
7. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Röhrich J; Zörntlein S; Becker J; Urban R
J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
[TBL] [Abstract][Full Text] [Related]
8. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
Musshoff F; Hokamp EG; Bott U; Madea B
Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
[TBL] [Abstract][Full Text] [Related]
11. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
Samyn N; De Boeck G; Verstraete AG
J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
[TBL] [Abstract][Full Text] [Related]
12. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
Huestis MA
Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
[No Abstract] [Full Text] [Related]
13. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
[TBL] [Abstract][Full Text] [Related]
14. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
15. Roadside drug testing: comparison of two legal approaches in Belgium.
Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
[TBL] [Abstract][Full Text] [Related]
16. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
17. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
[TBL] [Abstract][Full Text] [Related]
18. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Matzopoulos R; Lasarow A; Bowman B
Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
[TBL] [Abstract][Full Text] [Related]
19. Drugs in oral fluid in randomly selected drivers.
Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
[TBL] [Abstract][Full Text] [Related]
20. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
